Compliance and the therapeutic effect in patients with arterial hypertension

H Horvathova1, K Kimlikova, I Balazovjech

  • 1IInd Department of Internal Medicine, University Hospital, Comenius University, Bratislava, Slovakia. henrieta.horvathova@yahoo.com

Insights

Patient compliance significantly impacts hypertension treatment outcomes. Improving patient cooperation and adherence to medication and lifestyle changes is crucial for effective blood pressure control and preventing complications.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Essential hypertension management requires understanding treatment efficacy and patient adherence.
  • Hypertension outpatient departments monitor patient progress and treatment effectiveness.

Purpose of the Study:

  • To analyze the therapeutic effect of hypertension treatment.
  • To evaluate the influence of patient cooperation on treatment effectiveness.
  • To assess the impact of adherence on blood pressure reduction.

Main Methods:

  • Retrospective analysis of medical records for 101 essential hypertension patients.
  • Evaluation of treatment effectiveness and patient compliance using questionnaires.
  • Monitoring blood pressure changes and adherence to medication and lifestyle modifications.

Main Results:

  • Pharmacological treatment normalized blood pressure in 28% of patients, with a statistically significant drop from 146/90 mmHg to 129/82 mmHg.
  • Only 7% of patients demonstrated full compliance; compliant patients showed more marked blood pressure reduction.
  • Low patient compliance was observed for non-medicamentous treatments, including salt intake reduction, smoking cessation, and weight reduction.

Conclusions:

  • Treatment for arterial hypertension is often insufficient, with better outcomes in earlier stages.
  • A significant percentage of patients exhibit non-compliance, negatively affecting blood pressure control.
  • Patient compliance is positively correlated with blood pressure reduction, emphasizing the need for regular monitoring and patient motivation for long-term management and complication prevention.
Abstract

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.